| Translated title of the contribution | 在台灣以抗血管內皮生長因子治療新生血管年齡相關性黃斑部病變之成本效益分析:使用Bevacizumab、Ranibizumab及Aflibercept |
|---|---|
| Original language | American English |
| Supervisors/Advisors |
|
| State | Published - 2024 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver